Anixa Biosciences Inc (ANIX)
3.00
+0.00%
Anixa Biosciences Inc (ANIX) is currently trading at $3.00. This represents a gain of 0% from the previous session. With a market capitalization of $0.10B, ANIX is a key component of the Health Care sector. Investors looking to trade ANIX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ANIX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Anixa Biosciences Inc (ANIX) shows a bullish trend. Analysts are watching the 3.05 level closely.
Fundamentals
Mkt Cap0.10B
P/E Ratio0.0000
Volume57,378
60-Day Technical Chart
Advanced Charting
Need more indicators for ANIX? Use the world's #1 platform.
Open ANIX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $3
| Metric |
ANIX +0.00% |
RR +7.20% |
EVH +18.36% |
CCCC +16.95% |
|---|---|---|---|---|
| Price | $3.00 | $2.76 | $3.04 | $2.80 |
| Mkt Cap | $0.10B | $0.62B | $0.34B | $0.27B |
| - | View → | View → | View → |
Latest Headlines
Co-inventor of Anixa cancer CAR-T to headline 2026 cell therapy retreat
Stock Titan • Feb 23, 2026
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
PR Newswire • Feb 2, 2026
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance • Nov 5, 2025
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
PR Newswire • Feb 9, 2026
$ANIX stock is up 19% today. Here's what we see in our data.
Quiver Quantitative • Oct 7, 2025
● Gemini Agentic AI Analyst Insight for ANIX
Market Education
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
- Trump’s Latest Tariffs Send Shockwaves Across U.S. Economy Sep 26, 2025
- Money manifesting videos - POS and used by Nutcases Jul 16, 2023
External Research